By Lucas Berenbrok, Janice L. Pringle and Joni Carroll / The Conversation On March 29, 2023, the U.S. Food and Drug Administration approved Narcan for over-the-counter sale. Narcan is the 4-milligram nasal spray version of naloxone, a medication that can quickly counteract an opioid overdose. The FDA’s greenlighting of over-the-counter naloxone means that it will be available for […]
The post FDA Approval of Over-the-Counter Narcan Is an Important Step in the Effort to Combat the US Opioid Crisis appeared first on scheerpost.com.